Improving Efficacy Without Increasing Side Effects? Exploring the Impact of a Novel GLP-1–Glucagon Dual Receptor Agonist Upon Metabolic Dysfunction-Associated Steatohepatitis

Gastroenterology 2026

View at publisher

Authors: Benjamin Harvey Mullish

DOI: 10.1053/j.gastro.2026.01.016

Cited by: 0

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Diabetes Treatment and Management Diabetes Cardiovascular Risks and Lipoproteins